China Large Molecule Bioanalytical Testing Services Market Size & Outlook

The large molecule bioanalytical testing services market in China is expected to reach a projected revenue of US$ 147.6 million by 2030. A compound annual growth rate of 9.6% is expected of China large molecule bioanalytical testing services market from 2022 to 2030.

Revenue, 2021 (US$M)
$64.5
Forecast, 2030 (US$M)
$147.6
CAGR, 2022 - 2030
9.6%
Report Coverage
China

China large molecule bioanalytical testing services market, 2018-2030 (US$M)

China

Related Markets

China large molecule bioanalytical testing services market highlights

  • The China large molecule bioanalytical testing services market generated a revenue of USD 64.5 million in 2021 and is expected to reach USD 147.6 million by 2030.
  • The China market is expected to grow at a CAGR of 9.6% from 2022 to 2030.
  • In terms of segment, clinical was the largest revenue generating phase in 2021.
  • Preclinical is the most lucrative phase segment registering the fastest growth during the forecast period.


Large molecule bioanalytical testing services market data book summary

Market revenue in 2021USD 64.5 million
Market revenue in 2030USD 147.6 million
Growth rate9.6% (CAGR from 2021 to 2030)
Largest segmentClinical
Fastest growing segmentPreclinical
Historical data2018 - 2020
Base year2021
Forecast period2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPreclinical, Clinical
Key market players worldwideLabcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc


Other key industry trends

  • In terms of revenue, China accounted for 4.0% of the global large molecule bioanalytical testing services market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China large molecule bioanalytical testing services market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 58.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Large Molecule Bioanalytical Testing Services Market Scope

Large molecule bioanalytical testing services market segmentation & scope
With Antibody
Without Antibody (ELISA Based Assay)
Clinical
Pharmacokinetics
ADA
Others
ADME
PD
Bioavailability
Bioequivalence
Other Tests
Oncology
Infectious Diseases
Cardiology
Neurology
Others
CROs & CMOs
Sponsor Organizations
Others (Academic institute, etc.)
CROs & CMOs
Sponsor Organizations
Others (Academic institute, etc.)

Large Molecule Bioanalytical Testing Services Market Companies

Name Profile # Employees HQ Website

China large molecule bioanalytical testing services market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.


Clinical was the largest segment with a revenue share of 66.05% in 2021. Horizon Databook has segmented the China large molecule bioanalytical testing services market based on preclinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.


Rising number of clinical trials in the country will drive the market for large molecule bioanalytical testing over the forecast period. For instance, China conducted 46,149 clinical trials between 1999 and 2019, according to WHO’s ICTRP.

This contributes to around 8.8% of total clinical trials conducted globally in the same period. Furthermore, according to the World Bank, the healthcare expenditure of China was 5.4% of its GDP in 2018. Significant healthcare expenditure in the country will drive the large molecule bioanalytical testing market as well.

Favorable government policies, such as the “Made in China 2025,” will also improve funding of biopharmaceutical R&D. Such policies in the country will are expected to drive market growth in China. Moreover, significantly high geriatric population will augment the need for advanced health, driving the large molecule bioanalytical testing market.

Reasons to subscribe to China large molecule bioanalytical testing services market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China large molecule bioanalytical testing services market databook

  • Our clientele includes a mix of large molecule bioanalytical testing services market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China large molecule bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into China large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China large molecule bioanalytical testing services market size, by phase, 2018-2030 (US$M)

China Large Molecule Bioanalytical Testing Services Market Outlook Share, 2021 & 2030 (US$M)

China large molecule bioanalytical testing services market size, by phase, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more